ALKS
USDAlkermes plc Ordinary Shares
Preço em tempo real
Gráfico de preços
Métricas-chave
Métricas de mercado
Abertura
$30.000
Máximo
$30.630
Mínimo
$29.770
Volume
0.42M
Fundamentos da empresa
Capitalização de mercado
5.0B
Setor
Drug Manufacturers - Specialty & Generic
País
Ireland
Estatísticas de negociação
Volume médio
2.00M
Bolsa de valores
NMS
Moeda
USD
Faixa de 52 semanas
Notícias relacionadas
Wells Fargo Maintains Overweight on Alkermes, Lowers Price Target to $42
Wells Fargo analyst Benjamin Burnett maintains Alkermes with a Overweight and lowers the price target from $44 to $42.
Needham Maintains Buy on Alkermes, Raises Price Target to $44
Needham analyst Ami Fadia maintains Alkermes with a Buy and raises the price target from $43 to $44.
Alkermes plc Reports Third Quarter 2025 Financial Results
Alkermes plc (Nasdaq: ALKS) today reported financial results for the third quarter of 2025. "Alkermes delivered another successful quarter, achieving ...
Mizuho Maintains Outperform on Alkermes, Raises Price Target to $45
Mizuho analyst Uy Ear maintains Alkermes with a Outperform and raises the price target from $40 to $45.
Piper Sandler Reiterates Overweight on Alkermes, Raises Price Target to $45
Piper Sandler analyst David Amsellem reiterates Alkermes with a Overweight and raises the price target from $38 to $45.
RBC Capital Maintains Outperform on Alkermes, Raises Price Target to $47
RBC Capital analyst Leonid Timashev maintains Alkermes with a Outperform and raises the price target from $45 to $47.
Ações relacionadas
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.